Literature DB >> 22105997

Effects of systemic versus local administration of corticosteroids on mucosal tolerance.

Jerome Kerzerho1, Daniela Wunsch, Natacha Szely, Hellmuth-Alexander Meyer, Lisa Lurz, Lars Röse, Ulrich Wahn, Omid Akbari, Philippe Stock.   

Abstract

Respiratory exposure to allergen induces T cell tolerance and protection against the development of airway hyperactivity in animal models of asthma. Whereas systemic administration of dexamethasone during the delivery of respiratory Ag has been suggested to prevent the development of mucosal tolerance, the effects of local administration of corticosteroids, first-line treatment for patients with bronchial asthma, on mucosal tolerance remain unknown. To analyze the effects of systemic versus local administration of different types of corticosteroids on the development of mucosal tolerance, mice were exposed to respiratory allergen to induce mucosal tolerance with or without systemic or intranasal application of different doses of dexamethasone or prednisolone. After the induction of mucosal tolerance, proliferation of T cells was inhibited in tolerized mice, whereas systemic applications of corticosteroids restored T cell proliferation and secretion of Th2 cytokines. In contrast, inhaled corticosteroids showed no effect on both T cell proliferation and cytokine secretion. In addition, mice systemically treated with corticosteroids showed an increased airway hyperactivity with a significant lung inflammation, but also an increased T effector cells/regulatory T cells ratio in the second lymphoid organs when compared with mice that receive corticosteroids by inhalation. These results demonstrate that local administration of corticosteroids has no effect on the development of immune tolerance in contrast to systemically applied corticosteroids. Furthermore, although different concentrations of corticosteroids are administered to patients, our results demonstrated that the route of administration rather than the doses affects the effect of corticosteroids on respiratory tolerance induction. Considering the broad application of corticosteroids in patients with allergic disease and asthma, the route of administration of steroid substances seems crucial in terms of treatment and potential side effects. These findings may help elucidate the apparently contradicting results of corticosteroid treatment in allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105997      PMCID: PMC3253659          DOI: 10.4049/jimmunol.1101405

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Hydrocortisone and IL-4 induce IgE isotype switching in human B cells.

Authors:  H H Jabara; D J Ahern; D Vercelli; R S Geha
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

2.  Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10.

Authors:  D Rea; C van Kooten; K E van Meijgaarden; T H Ottenhoff; C J Melief; R Offringa
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

3.  Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL-4 and hydrocortisone.

Authors:  H H Jabara; R Loh; N Ramesh; D Vercelli; R S Geha
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

4.  Corticosteroid effect on immunoglobulins.

Authors:  G A Settipane; R K Pudupakkam; J H McGowan
Journal:  J Allergy Clin Immunol       Date:  1978-09       Impact factor: 10.793

5.  Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.

Authors:  G M Gauvreau; J Doctor; R M Watson; M Jordana; P M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

6.  Synthetic glucocorticoids potentiate IgE synthesis. Influence of steroid and nonsteroid hormones on human in vitro IgE secretion.

Authors:  H G Nüsslein; G Weber; J R Kalden
Journal:  Allergy       Date:  1994-05       Impact factor: 13.146

7.  Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.

Authors:  A M Bentley; Q Hamid; D S Robinson; E Schotman; Q Meng; B Assoufi; A B Kay; S R Durham
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

8.  Deposition of pressurised aerosols in the human respiratory tract.

Authors:  S P Newman; D Pavia; F Morén; N F Sheahan; S W Clarke
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

9.  Glucocorticoids suppress the production of interleukin 4 by human lymphocytes.

Authors:  C Y Wu; C Fargeas; T Nakajima; G Delespesse
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

10.  In vivo effects of glucocorticoids on IgE production.

Authors:  G Zieg; G Lack; R J Harbeck; E W Gelfand; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1994-08       Impact factor: 10.793

View more
  8 in total

1.  Intra-Organ Delivery of Nanotherapeutics for Organ Transplantation.

Authors:  Bilal Hussain; Vivek Kasinath; Joren C Madsen; Jonathan Bromberg; Stefan G Tullius; Reza Abdi
Journal:  ACS Nano       Date:  2021-10-29       Impact factor: 18.027

2.  Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort.

Authors:  Ninad S Chaudhary; John P Donnelly; Justin X Moore; John W Baddley; Monika M Safford; Henry E Wang
Journal:  Crit Care       Date:  2017-07-13       Impact factor: 9.097

Review 3.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 4.  Effects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysis.

Authors:  Thiago Mamôru Sakae; Rosemeri Maurici; Daisson José Trevisol; Marcia Margaret Menezes Pizzichini; Emílio Pizzichini
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

5.  Interleukin-25 is detrimental for recovery after spinal cord injury in mice.

Authors:  Dearbhaile Dooley; Evi Lemmens; Peter Ponsaerts; Sven Hendrix
Journal:  J Neuroinflammation       Date:  2016-05-06       Impact factor: 8.322

Review 6.  The Role of the Vagus Nerve in Cancer Prognosis: A Systematic and a Comprehensive Review.

Authors:  Marijke De Couck; Ralf Caers; David Spiegel; Yori Gidron
Journal:  J Oncol       Date:  2018-07-02       Impact factor: 4.375

Review 7.  Oral tolerance as antigen-specific immunotherapy.

Authors:  Natália Pinheiro-Rosa; Lícia Torres; Mariana de Almeida Oliveira; Marcos Felipe Andrade-Oliveira; Mauro Andrade de Freitas Guimarães; Monique Macedo Coelho; Juliana de Lima Alves; Tatiani Uceli Maioli; Ana M Caetano Faria
Journal:  Immunother Adv       Date:  2021-08-25

8.  Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus.

Authors:  Sotiria Davidopoulou; Haris Theodoridis; Konstantinos Nazer; Eftichia Kessopoulou; George Menexes; Sotirios Kalfas
Journal:  J Oral Microbiol       Date:  2014-12-04       Impact factor: 5.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.